AUPP310798A0 - Vehicle system for a composition comprising a piperidinopyrimidine derivative - Google Patents

Vehicle system for a composition comprising a piperidinopyrimidine derivative

Info

Publication number
AUPP310798A0
AUPP310798A0 AUPP3107A AUPP310798A AUPP310798A0 AU PP310798 A0 AUPP310798 A0 AU PP310798A0 AU PP3107 A AUPP3107 A AU PP3107A AU PP310798 A AUPP310798 A AU PP310798A AU PP310798 A0 AUPP310798 A0 AU PP310798A0
Authority
AU
Australia
Prior art keywords
composition
piperidinopyrimidine derivative
weight
vehicle system
piperidinopyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP3107A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stiefel Research Australia Pty Ltd
Original Assignee
Soltec Research Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3807366&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AUPP310798(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Soltec Research Pty Ltd filed Critical Soltec Research Pty Ltd
Priority to AUPP3107A priority Critical patent/AUPP310798A0/en
Publication of AUPP310798A0 publication Critical patent/AUPP310798A0/en
Priority to ES06012033.4T priority patent/ES2665271T3/es
Priority to JP2000544327A priority patent/JP3710380B2/ja
Priority to EP99914373A priority patent/EP1073439B1/en
Priority to EP06012033.4A priority patent/EP1695708B1/en
Priority to DE69932158T priority patent/DE69932158T2/de
Priority to CA002328950A priority patent/CA2328950C/en
Priority to BRPI9909796-6B1A priority patent/BR9909796B1/pt
Priority to PCT/AU1999/000294 priority patent/WO1999053923A1/en
Priority to PT99914373T priority patent/PT1073439E/pt
Priority to AT99914373T priority patent/ATE331517T1/de
Priority to DK06012033.4T priority patent/DK1695708T3/en
Priority to ES99914373T priority patent/ES2268856T3/es
Priority to PT60120334T priority patent/PT1695708T/pt
Priority to AU33232/99A priority patent/AU757601B2/en
Priority to DK99914373T priority patent/DK1073439T3/da
Priority to US10/124,197 priority patent/US6946120B2/en
Priority to JP2003178898A priority patent/JP4338455B2/ja
Priority to US10/949,116 priority patent/US20050037060A1/en
Priority to JP2007050885A priority patent/JP2007137899A/ja
Priority to CY20181100524T priority patent/CY1120513T1/el
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AUPP3107A 1998-04-22 1998-04-22 Vehicle system for a composition comprising a piperidinopyrimidine derivative Abandoned AUPP310798A0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
AUPP3107A AUPP310798A0 (en) 1998-04-22 1998-04-22 Vehicle system for a composition comprising a piperidinopyrimidine derivative
AU33232/99A AU757601B2 (en) 1998-04-22 1999-04-20 Pharmaceutical composition
DK99914373T DK1073439T3 (da) 1998-04-22 1999-04-20 Farmaceutisk sammensætning
PT99914373T PT1073439E (pt) 1998-04-22 1999-04-20 Composição farmacêutica
ES99914373T ES2268856T3 (es) 1998-04-22 1999-04-20 Composicion farmaceutica.
EP99914373A EP1073439B1 (en) 1998-04-22 1999-04-20 Pharmaceutical composition
EP06012033.4A EP1695708B1 (en) 1998-04-22 1999-04-20 Highly concentrated minoxidil composition
DE69932158T DE69932158T2 (de) 1998-04-22 1999-04-20 Pharmazeutische zusammenstellungen
CA002328950A CA2328950C (en) 1998-04-22 1999-04-20 Piperidinopyrimidine derivatives for topical application
BRPI9909796-6B1A BR9909796B1 (pt) 1998-04-22 1999-04-20 "derivados de piperidinopirimidina para aplicação tópica"
PCT/AU1999/000294 WO1999053923A1 (en) 1998-04-22 1999-04-20 Pharmaceutical composition
ES06012033.4T ES2665271T3 (es) 1998-04-22 1999-04-20 Composición de minoxidil a alta concentración
AT99914373T ATE331517T1 (de) 1998-04-22 1999-04-20 Pharmazeutische zusammenstellungen
DK06012033.4T DK1695708T3 (en) 1998-04-22 1999-04-20 Highly concentrated minoxidil composition
JP2000544327A JP3710380B2 (ja) 1998-04-22 1999-04-20 医薬溶液
PT60120334T PT1695708T (pt) 1998-04-22 1999-04-20 Composição farmacêutica
US10/124,197 US6946120B2 (en) 1998-04-22 2002-04-16 Pharmaceutical composition
JP2003178898A JP4338455B2 (ja) 1998-04-22 2003-06-24 医薬溶液
US10/949,116 US20050037060A1 (en) 1998-04-22 2004-09-10 Pharmaceutical composition
JP2007050885A JP2007137899A (ja) 1998-04-22 2007-03-01 医薬溶液
CY20181100524T CY1120513T1 (el) 1998-04-22 2018-05-18 Υψηλης συμπυκνωσης συνθεση μινοξιδιλης

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP3107A AUPP310798A0 (en) 1998-04-22 1998-04-22 Vehicle system for a composition comprising a piperidinopyrimidine derivative

Publications (1)

Publication Number Publication Date
AUPP310798A0 true AUPP310798A0 (en) 1998-05-14

Family

ID=3807366

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPP3107A Abandoned AUPP310798A0 (en) 1998-04-22 1998-04-22 Vehicle system for a composition comprising a piperidinopyrimidine derivative

Country Status (13)

Country Link
US (2) US6946120B2 (enExample)
EP (2) EP1073439B1 (enExample)
JP (3) JP3710380B2 (enExample)
AT (1) ATE331517T1 (enExample)
AU (1) AUPP310798A0 (enExample)
BR (1) BR9909796B1 (enExample)
CA (1) CA2328950C (enExample)
CY (1) CY1120513T1 (enExample)
DE (1) DE69932158T2 (enExample)
DK (2) DK1695708T3 (enExample)
ES (2) ES2268856T3 (enExample)
PT (2) PT1695708T (enExample)
WO (1) WO1999053923A1 (enExample)

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9504265D0 (en) 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
AUPO983897A0 (en) 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
AUPP310798A0 (en) 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
JPH11349451A (ja) * 1998-06-08 1999-12-21 Taisho Pharmaceut Co Ltd 育毛剤
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US6342496B1 (en) * 1999-03-01 2002-01-29 Sepracor Inc. Bupropion metabolites and methods of use
JP4892786B2 (ja) * 2000-04-07 2012-03-07 大正製薬株式会社 持続性育毛製剤
ES2245980T3 (es) * 2000-04-07 2006-02-01 Taisho Pharmaceutical Co., Ltd Composiciones estimulantes del crecimiento capilar.
JP4940527B2 (ja) * 2000-04-07 2012-05-30 大正製薬株式会社 持続性育毛組成物
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US7442369B1 (en) * 2000-08-09 2008-10-28 Mcneil Ab Compositions of minoxidil
AUPR048600A0 (en) * 2000-10-02 2000-10-26 Soltec Research Pty Ltd Pharmaceutical vehicle
UA80094C2 (en) * 2001-05-15 2007-08-27 Taisho Pharmaceutical Co Ltd Minoxidil-containing liquid composition and use of arginine for preventing from suffering the thermal coloration
SE0104421D0 (sv) * 2001-12-21 2001-12-21 Ponsus Pharma Ab New composition
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
EA014372B1 (ru) 2003-01-24 2010-10-29 Стифел Рисерч Оустрэйлиа Пти Лтд. Пена на основе фосфата клиндамицина
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US7186416B2 (en) 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US7199090B2 (en) 2003-09-29 2007-04-03 Ethena Healthcare Inc. High alcohol content gel-like and foaming compositions comprising an alcohol and fluorosurfactant
GB0323908D0 (en) * 2003-10-11 2003-11-12 Nupharm Lab Ltd Pharmaceutical foam formulation
WO2005067873A1 (en) * 2003-12-22 2005-07-28 Regrowth, Llc Topical solutions comprising high concentrations of piperidinopyrimidine derivatives and methods of use thereof
US20050163811A1 (en) * 2004-01-23 2005-07-28 Richard Lee Topical solutions comprising high concentrations of piperidinopyrimidine derivatives and methods of use thereof
US20060057075A1 (en) * 2004-08-02 2006-03-16 Moshe Arkin Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof
US20060034779A1 (en) * 2004-08-02 2006-02-16 Agis Industries (1983) Ltd. Foamable compositions containing vitamin D3 analogues, processes for preparing same and methods of treatment utilizng same
DE102004062775A1 (de) 2004-12-21 2006-06-29 Stockhausen Gmbh Alkoholischer Pumpschaum
EP3292757B1 (en) 2005-03-07 2025-09-03 Deb IP Limited High alcohol content foaming compositions with silicone-based surfactants
AU2006298442A1 (en) 2005-05-09 2007-04-12 Foamix Ltd. Saccharide foamable compositions
EP1917072B1 (en) 2005-06-01 2013-02-27 Stiefel Research Australia Pty Ltd Vitamin formulation
US8147815B2 (en) * 2005-12-16 2012-04-03 Celmatrix Corporation Topical administration carrier composition and therapeutic formulations comprising same
BRPI0709674A2 (pt) 2006-03-31 2011-12-06 Stiefel Research Australia Pty Ltd. gel de suspensão espumante
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
KR100893469B1 (ko) * 2006-12-22 2009-04-17 씨제이제일제당 (주) 피부 투과성이 우수한 미녹시딜 함유 발모용 외용액제조성물
US8580860B2 (en) * 2007-02-23 2013-11-12 Gojo Industries, Inc. Foamable alcoholic composition
US8021649B2 (en) 2007-02-22 2011-09-20 Cronk Peter J Continuous spray scalp therapy and dispensing systems for same
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
EP2242476A2 (en) 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
JP5420946B2 (ja) 2009-03-23 2014-02-19 富士フイルム株式会社 胆汁酸を含むミノキシジル水性組成物
JP2010222317A (ja) * 2009-03-25 2010-10-07 Shiseido Co Ltd 水中油型乳化化粧料
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
JP5833007B2 (ja) 2009-08-31 2015-12-16 ドクター・レディーズ・ラボラトリーズ・リミテッド ステロイドを含む局所製剤
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
EP2482788B1 (en) 2009-10-02 2022-12-14 Journey Medical Corporation Topical tetracycline compositions
US20110189114A1 (en) * 2010-01-29 2011-08-04 Nyangenya Maniga minoxidil composition and non-aerosol, non-spray foam method of delivery therefor
US9271917B2 (en) 2010-01-29 2016-03-01 Nyangenya Maniga Method and apparatus for delivery of a measured dosage of a non-aerosol, non-spray foam composition of minoxidil
WO2012040342A2 (en) * 2010-09-21 2012-03-29 Conrex Pharmaceutical Corporation Restoration of hair
WO2012078649A1 (en) 2010-12-06 2012-06-14 Follica, Inc. Methods for treating baldness and promoting hair growth
US9717741B2 (en) 2012-10-11 2017-08-01 Anaplasi Pharmaceuticals Llc Method and compositions for treating psoriasis
CA2886024C (en) 2012-10-11 2019-10-29 Anaplasi Pharmaceuticals Llc Method and compositions for treating psoriasis
WO2014122436A1 (en) 2013-02-07 2014-08-14 Cipla House Topical pharmaceutical compositions comprising minoxidil
US8642097B1 (en) 2013-03-19 2014-02-04 Nyangenya Maniga Natural product energy drink and method of use thereof
WO2014184173A1 (en) 2013-05-14 2014-11-20 Montero Gida Sanayi Ve Ticaret A.S. Hair care formulations
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
US9474699B2 (en) 2014-03-31 2016-10-25 Johnson & Johnson Consumer Inc. Compostions and methods for enhancing the topical application of a basic benefit agent
US9468606B2 (en) 2014-03-31 2016-10-18 Johnson & Johnson Consumer Inc. Compostions and methods for enhancing the topical application of an acidic benefit agent
EP3154504B1 (en) 2014-06-16 2020-12-02 Johnson & Johnson Consumer Inc. Compositions and methods for enhancing the topical application of a color cosmetic
US20150359742A1 (en) 2014-06-17 2015-12-17 Johnson & Johnson Consumer Inc. Compositions and methods for enhancing the topical application of a benefit agent including powder to liquid particles and a second powder
US9675537B2 (en) 2014-06-30 2017-06-13 Johnson & Johnson Consumer Inc. Hair growth composition and method
JP7072346B2 (ja) * 2015-03-27 2022-05-20 大正製薬株式会社 ローション剤
WO2016159916A1 (en) * 2015-03-31 2016-10-06 Ogi̇g Sağlik Ürünleri̇ Ve Hi̇zmetleri̇ Sanayi̇ Ti̇caret Li̇mi̇ted Şi̇rketi̇ A foamy pharmaceutical formulation used in dermatological diseases
US20170216177A1 (en) * 2015-05-18 2017-08-03 Angelo Perry Thrower Hair regrowth treatment and growth stimulant
AU2016326143B2 (en) 2015-09-27 2021-05-27 Follica, Inc. Needling device and drug applicator
EP3359198B1 (en) 2015-10-06 2020-05-13 Assos Ilaç Kimya Gida Ürünleri Üretim Ve Tic. A.S. Topical minoxidil composition
US10561593B2 (en) 2015-12-28 2020-02-18 Johnson & Johnson Consumer Inc. Hair growth composition and method
CN105434352A (zh) * 2015-12-31 2016-03-30 浙江万晟药业有限公司 一种米诺地尔泡沫剂及其制备方法与应用
JP2018048105A (ja) * 2016-01-22 2018-03-29 大正製薬株式会社 外用組成物
JP2018048104A (ja) * 2016-01-22 2018-03-29 大正製薬株式会社 外用組成物
JP6848565B2 (ja) * 2016-03-30 2021-03-24 大正製薬株式会社 エアゾール剤
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US10736905B1 (en) 2016-09-09 2020-08-11 Shahin Fatholahi Nefopam dosage forms and methods of treatment
JP7366515B2 (ja) * 2016-09-15 2023-10-23 大正製薬株式会社 外用組成物
US9962444B2 (en) 2016-09-27 2018-05-08 Shane Malek Pharmacokinetically extended action topical hair growth formulation, and administration method
US10702495B2 (en) 2017-02-20 2020-07-07 Nexien Biopharma, Inc. Method and compositions for treating dystrophies and myotonia
US10736874B1 (en) 2017-09-08 2020-08-11 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
US11446311B2 (en) 2017-09-08 2022-09-20 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
JP2019210268A (ja) * 2018-05-30 2019-12-12 ダイヤ製薬株式会社 外用剤及び外用剤の製造方法
US20220354764A1 (en) 2018-05-30 2022-11-10 Follica, Inc. Methods for promoting hair growth
WO2020206623A1 (en) * 2019-04-10 2020-10-15 Goldfinch Bio, Inc. Crystal forms
EP3965724A4 (en) 2019-05-06 2023-05-17 Spinart, LLC FORMULATIONS AND PROCESSES FOR THE MANUFACTURE OF STABLE COSMETIC COMPOSITIONS
EP3750528A1 (en) 2019-06-11 2020-12-16 Nexien Biopharma, Inc. Compositions for treating dystrophies and myotonia
EP3991734B1 (en) 2019-06-28 2024-11-27 Gurus BioPharm Inc. Agent for the treatment of alopecia and promoting hair growth
US11253518B2 (en) 2019-08-07 2022-02-22 Aneira Pharma, Inc. Methods and compositions for the treatment of hair loss
US12539302B2 (en) 2019-08-07 2026-02-03 Aneira Pharma, Inc. Methods and compositions for the treatment of hair loss
BR102021003531A2 (pt) * 2021-02-24 2022-08-30 Eurofarma Laboratorios S.A. Composição farmacêutica tópica espumável
JP2025536556A (ja) 2022-10-25 2025-11-07 ヴェラダーミクス インコーポレイテッド 放出調節ミノキシジル用組成物および使用方法
TW202444338A (zh) 2023-04-07 2024-11-16 義大利商卡斯歐皮亞股份公司 克拉司酮與米諾地爾之組合療法
CN116919892B (zh) * 2023-08-03 2024-08-16 济南中海医药科技有限公司 一种米诺地尔外用溶液的制备方法
WO2025172818A1 (en) * 2024-02-14 2025-08-21 Cassiopea S.P.A. Pyrilutamide combination therapy
WO2026057588A1 (en) 2024-09-10 2026-03-19 Cassiopea S.P.A. Clascoterone and minoxidil combination therapy for use in treating hair loss
CN118908900B (zh) * 2024-10-10 2025-01-28 山东则正医药技术有限公司 一种米诺地尔乳酸盐晶型及其制备方法和应用

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US515836A (en) * 1894-03-06 Basin-clamp
US4139619A (en) 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
US4596812A (en) 1976-05-24 1986-06-24 The Upjohn Company Methods and solutions for treating male pattern alopecia
IT1066697B (it) * 1976-11-08 1985-03-12 Manetti & Roberts Italo Brit Attivatore per composizioni cosmetiche e composizioni cosmetiche che lo contengono
US5183817A (en) * 1981-02-17 1993-02-02 Bazzano Gail S Combinations of retinoids and minoxidil-type compounds for hair growth
EP0093770B1 (en) * 1981-11-09 1991-06-19 BAZZANO, Gail S The use of retinoids and minoxidil (2,4-diamino-6-piperidino-pyrimidine-3-oxide) to increase the rate of growth of human scalp hair and to treat certain types of alopecias
AU565146B2 (en) 1983-10-24 1987-09-03 Connetics Australia Pty Ltd Foamable biocide composition
WO1986000196A1 (en) 1984-06-21 1986-01-16 Soltec Research Pty. Ltd. Aerosol product
JPS61197161A (ja) 1985-02-25 1986-09-01 Amada Co Ltd ドレツシング装置
IT1201436B (it) * 1985-07-19 1989-02-02 Vincenzo Zappia Formulazioni topiche a lento rilascio
EP0249397B1 (en) * 1986-06-13 1992-08-12 The Procter & Gamble Company Improved penetrating topical pharmaceutical compositions
US5041439A (en) * 1986-06-13 1991-08-20 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
LU86548A1 (fr) 1986-08-07 1988-03-02 Oreal Composition sous forme de gel pour induire et stimuler la croissance des cheveux et diminuer leur chute a base de derives de piperidino-pyrimidine
DE3777656D1 (de) 1986-08-08 1992-04-23 Upjohn Co Mittel zur behandlung von alopezien.
WO1988001863A1 (en) 1986-09-12 1988-03-24 The Upjohn Company Foams for delivery of minoxidil
JPS63150211A (ja) 1986-12-15 1988-06-22 Taisho Pharmaceut Co Ltd ミノキシジル配合外用剤
AU618517B2 (en) 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US5389677B1 (en) 1986-12-23 1997-07-15 Tristrata Inc Method of treating wrinkles using glycalic acid
US4882182A (en) 1987-01-08 1989-11-21 Soltec Research Pty. Ltd. Aerosol product
US5030442A (en) 1987-03-30 1991-07-09 Liposome Technology, Inc. Non-crystalline minoxidil composition
US4828837A (en) 1987-03-30 1989-05-09 Liposome Technology, Inc. Non-crystalline minoxidil composition, its production and application
JPH0745387B2 (ja) 1987-09-09 1995-05-17 株式会社資生堂 発毛、養毛促進剤
JP2810040B2 (ja) * 1987-09-09 1998-10-15 株式会社資生堂 頭皮・頭髪用養毛料
JP2810041B2 (ja) 1987-09-09 1998-10-15 株式会社資生堂 頭皮・頭髪用養毛料
EP0334960B1 (en) 1987-10-02 1994-08-17 Shiseido Company Limited Hair tonic
US4866067A (en) * 1987-12-07 1989-09-12 Ricerche De Schiena s.n.c del Dr. Michele Giuseppe Di Schiena & C. 6-piperidino-2,4-diaminopyrimidine-3-oxide salt of 3-carboxypyridine n-oxide and topical, related compositions
US4888354A (en) 1987-12-21 1989-12-19 Theratech, Inc. Skin penetration enhancement using free base and acid addition salt combinations of active agents
ATE90195T1 (de) 1988-02-18 1993-06-15 Upjohn Co Minoxidil-gel.
US5225189A (en) 1988-02-18 1993-07-06 The Upjohn Company Minoxidil gel
AU619256B2 (en) 1988-03-03 1992-01-23 Connetics Australia Pty Ltd Acne treatment
LU87249A1 (fr) 1988-06-17 1990-02-28 Oreal Composition pour induire et stimuler la croissance des cheveux et/ou freiner leur chute,a base d'un agent tensio-actif amphotere et d'un derive de pyrimidine
US4938953A (en) 1988-08-09 1990-07-03 The Upjohn Company Self-preserving conditioning shampoo formulation
US5104646A (en) 1989-08-07 1992-04-14 The Procter & Gamble Company Vehicle systems for use in cosmetic compositions
JP3004718B2 (ja) 1990-08-10 2000-01-31 ファルマシア・アンド・アップジョン・カンパニー カリウムチャネルオープナーおよび５α―レダクターゼ抑制剤を用いる育毛刺激
US5935554A (en) 1990-09-03 1999-08-10 Soltec Research Pty. Ltd. Concentrated aerosol space spray that is not an emulsion
EP1070752A3 (en) 1990-09-03 2003-08-27 Connetics Australia Pty Limited A concentrated aerosol space spray
AU1677292A (en) * 1991-03-19 1992-10-21 Procter & Gamble Company, The Hair care compositions having styling/conditioning agent and plasticizer
ZA94170B (en) 1993-01-20 1995-03-15 Soltec Res Pty Ltd Ectoparasiticidal formulation
JPH0748230A (ja) * 1993-07-31 1995-02-21 Hideo Horiuchi 育毛剤の製造法
FR2717683B1 (fr) 1994-03-22 1996-06-28 Fabre Pierre Cosmetique Composition capillaire à base de minoxidil.
GB9504265D0 (en) 1995-03-03 1995-04-19 Medeva Plc Corticosteroid-containing pharmaceutical composition
US5783202A (en) 1995-03-14 1998-07-21 Soltec Research Pty. Ltd. Pediculicidal mousse composition for killing head lice
FR2736824B1 (fr) * 1995-07-18 1997-10-10 Fabre Pierre Dermo Cosmetique Composition capillaire a base de minoxidil a faible teneur en solvant gras
JPH0971513A (ja) 1995-09-07 1997-03-18 Taisho Pharmaceut Co Ltd 育毛剤
JP3518096B2 (ja) 1995-09-29 2004-04-12 松下電器産業株式会社 映像記録再生機器の製造方法
US5834014A (en) * 1995-10-06 1998-11-10 The Regents Of The University Of Michigan Stimulation of hair follicles
JP4467085B2 (ja) * 1996-01-05 2010-05-26 大正製薬株式会社 ヒノキチオール含有組成物
JPH09188629A (ja) 1996-01-06 1997-07-22 Pola Chem Ind Inc 抗体産生細胞抑制剤及びそれを含有する組成物
US5788155A (en) 1996-06-28 1998-08-04 S. C. Johnson & Son, Inc. Air freshener dispenser device with dual cartridge capacity
US5838669A (en) 1996-08-28 1998-11-17 At&T Corp. Method of synchronizing satellite switched CDMA communication system
JP3061575B2 (ja) 1996-10-17 2000-07-10 日立建機株式会社 孔掘削装置
AUPO379596A0 (en) 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
JPH10158782A (ja) 1996-12-05 1998-06-16 Nkk Corp フォトエッチング時の穿孔性とプレス成形性に優れたシャドウマスク用鋼板及びその製造方法
JPH10265343A (ja) 1997-01-23 1998-10-06 Taisho Pharmaceut Co Ltd 持効性育毛剤
AU729411B2 (en) 1997-01-23 2001-02-01 Taisho Pharmaceutical Co., Ltd. Sustained release hair growth preparation
JPH10279437A (ja) * 1997-03-31 1998-10-20 Shiseido Co Ltd 頭髪用化粧料
AUPO688997A0 (en) 1997-05-20 1997-06-12 Soltec Research Pty Ltd Sunscreen composition
AUPO983897A0 (en) 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
JPH11302131A (ja) * 1998-04-15 1999-11-02 Shiseido Co Ltd 頭皮頭髪用化粧料
AUPP310798A0 (en) * 1998-04-22 1998-05-14 Soltec Research Pty Ltd Vehicle system for a composition comprising a piperidinopyrimidine derivative
JPH11349451A (ja) 1998-06-08 1999-12-21 Taisho Pharmaceut Co Ltd 育毛剤
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
AUPP583198A0 (en) 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US6383471B1 (en) 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
AUPQ002999A0 (en) 1999-04-29 1999-05-20 Soltec Research Pty Ltd Non-aqueous shampoo composition
ES2245980T3 (es) 2000-04-07 2006-02-01 Taisho Pharmaceutical Co., Ltd Composiciones estimulantes del crecimiento capilar.
US20030157046A1 (en) 2000-04-07 2003-08-21 Koji Imamura Minoxidil-containing preparations
JP4780429B2 (ja) 2000-04-07 2011-09-28 大正製薬株式会社 ミノキシジル含有製剤

Also Published As

Publication number Publication date
US20020172649A1 (en) 2002-11-21
EP1073439A1 (en) 2001-02-07
JP2002512192A (ja) 2002-04-23
EP1695708B1 (en) 2018-02-28
EP1073439B1 (en) 2006-06-28
CA2328950A1 (en) 1999-10-28
JP2004059587A (ja) 2004-02-26
JP3710380B2 (ja) 2005-10-26
CY1120513T1 (el) 2019-07-10
DK1695708T3 (en) 2018-04-23
EP1073439A4 (en) 2003-07-02
PT1695708T (pt) 2018-05-18
BR9909796B1 (pt) 2013-10-29
EP1695708A3 (en) 2012-07-18
JP2007137899A (ja) 2007-06-07
DE69932158D1 (de) 2006-08-10
ATE331517T1 (de) 2006-07-15
BR9909796A (pt) 2000-12-26
EP1695708A2 (en) 2006-08-30
US20050037060A1 (en) 2005-02-17
JP4338455B2 (ja) 2009-10-07
ES2665271T3 (es) 2018-04-25
WO1999053923A1 (en) 1999-10-28
PT1073439E (pt) 2006-11-30
DK1073439T3 (da) 2006-10-23
DE69932158T2 (de) 2007-05-10
CA2328950C (en) 2008-07-29
US6946120B2 (en) 2005-09-20
ES2268856T3 (es) 2007-03-16

Similar Documents

Publication Publication Date Title
EP1073439A4 (en) PHARMACEUTICAL COMPOSITIONS
CA2304958A1 (en) Bioadhesive compositions and methods for topical administration of active agents
IE871335L (en) Steroid formulations.
WO2001030336A3 (en) Pharmaceutical formulations comprising resveratrol and use thereof
WO2001032596A8 (en) Phenoxy carboxylic acid compounds and compositions for delivering active agents
WO2000016762A3 (en) Method for reducing nicotine dependency
KR970706021A (ko) N-치환-o-톨루이딘유도체로 이루어진 약용배합제 및 경피흡수형제제(MEDICINAL ADJUVANTS CONSISTIONG OF AN N-SUBSTITUED-o-TOLUIDING DERIVANTIVE, AND PERCUTANEOUSLY ABSORBALE PREPARATIONS COMPRISING THE ADJUVANTS)
AU3900300A (en) Improved aqueous solubility pharmaceutical formulations
CA2319515A1 (en) Anhydrous topical skin preparations
EP1690534A3 (en) Lipoic acid in topical compositions
CA2301017A1 (en) Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
IE890500L (en) 3-alkenyl-1-azabicyclo£3.2.0|hept-2-ene-2-carboxylic acid compounds
CA2012875A1 (en) Skin permeation enhancer compositions
WO2000037057A3 (en) Novel formulations comprising lipid-regulating agents
EP0740545A1 (en) Pharmaceutical ointment base
IE831611L (en) Topical anti-inflammatory compositions
AU2002361265A1 (en) Pharmaceutical composition for the treatment of psoriasis and other skin diseases
ES2002140A6 (es) Procedimiento para producir preparados de derivados de acido arilpropionico resorbibles por via transdermal y acuosos
MY101536A (en) Anti-inflammatory and analgesic tape for external use
US20170007539A1 (en) Pharmaceutical compositions comprising silica microspheres
WO2001085139A3 (en) Semi-solid delivery vehicle and pharmaceutical compositions
EP0723781A3 (en) Transdermal formulation of xanomeline
AUPR048600A0 (en) Pharmaceutical vehicle
CA2360300A1 (en) A transdermal composition of an antivomiting agent and a preparation containing the same
IL148241A0 (en) A composition for inhalation containing delta-9-tetrahydrocannabinol